Anti-Human CD49b (AK7) Mouse IgG2a Recombinant Antibody
CD49b Uni-rAbTM Recombinant Antibody for FC
Host / Isotype
Mouse / IgG2a
Reactivity
human
Applications
FC
Conjugate
Unconjugated
CloneNo.
AK7
Cat no : 65583-1-MR
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human peripheral blood platelets |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
65583-1-MR targets CD49b in FC applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Mouse / IgG2a |
Class | Recombinant |
Type | Antibody |
Immunogen | Human platelets |
Full Name | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
Calculated Molecular Weight | 126 kDa |
GenBank Accession Number | NM_002203 |
Gene Symbol | Integrin alpha 2 |
Gene ID (NCBI) | 3673 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
Background Information
CD49b, also known as alpha2 integrin, is a type I transmembrane glycoprotein which forms an adhesion molecule VLA-2 with beta1 integrin. CD49b is a receptor for many (extracellular) matrix and non-matrix molecules (PMID: 23847623). CD49b is expressed on numerous cell types including platelets, activated T cells, B cells, and monocytes. CD49b activation skews NK cell effector function to a phenotype that exhibits elevated IFN-γ production with a concomitant inhibition of motility and cytolytic function (PMID: 32971468, 32762681). The Anti-Human CD49b antibody, clone AK7, is derived from Human platelets.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CD49b antibody 65583-1-MR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |